Welcome to our dedicated page for Naturl Alt Intl SEC filings (Ticker: NAII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Natural Alternatives International, Inc. (NAII) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a NASDAQ-listed issuer incorporated in Delaware, NAI submits annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, along with proxy materials such as the definitive proxy statement on Schedule 14A.
For a company in the nutritional supplements and medicinal and botanical manufacturing sector, Form 10-K and Form 10-Q are central sources of information on segment performance for private-label contract manufacturing and patent and trademark licensing, including CarnoSyn® beta-alanine royalty, licensing and raw material sales. These filings also describe factors affecting results, such as manufacturing costs, factory capacity utilization, and sales mix between segments.
Form 8-K current reports document material events. Recent examples include an amended credit facility with Wells Fargo Bank extending NAI’s revolving line of credit and adding collateral, a Waiver and Release Agreement in which Wells Fargo waived certain financial covenant defaults, and a Manufacturing Agreement with The Juice Plus+ Company covering Juice Plus+ products in 24 countries. Other 8-K filings summarize outcomes of the annual meeting of stockholders, including votes on director elections, amendments to equity incentive plans, and advisory votes on executive compensation.
NAI’s DEF 14A definitive proxy statement outlines governance matters, annual meeting logistics, and proposals submitted to shareholders, including board elections, equity plan amendments, auditor ratification, and advisory compensation votes. These materials help investors understand the company’s governance framework and shareholder voting results.
On Stock Titan, NAII filings are updated in near real time from EDGAR, and AI-powered summaries highlight the key points of lengthy documents such as 10-Ks, 10-Qs, and 8-Ks. Users can quickly see what changed in new filings, how credit agreements and manufacturing contracts are structured, and how shareholder approvals may affect equity plans and governance, without reading every page of the underlying documents.
Dimensional Fund Advisors LP filed an amended Schedule 13G reporting passive beneficial ownership of Natural Alternatives International Inc. common stock as of 12/31/2025. The filing shows beneficial ownership of 384,497 shares, representing 6.2% of the company’s common stock. Dimensional has sole power to vote 379,548 shares and sole power to dispose of 384,497 shares.
The shares are owned by various funds and accounts it advises, and Dimensional may be deemed a beneficial owner only for Section 13(d) purposes. The firm certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of Natural Alternatives International.
Natural Alternatives International, Inc. entered into a Waiver and Release Agreement with Wells Fargo Bank after breaching certain financial covenants in its existing credit agreement. For the fiscal first quarter ended September 30, 2025, the company did not comply with the maximum net loss and fixed charge coverage ratio requirements under its revolving and term loan facilities. On December 17, 2025, Wells Fargo agreed to waive all of these defaults and confirmed that the credit agreement, security agreement and related deed of trust remain in full force and effect, allowing NAI to maintain its current borrowing arrangements.
Natural Alternatives International, Inc. reported the results of its annual stockholder meeting held on December 5, 2025. Stockholders elected Class II director Alan G. Dunn to continue serving until the next Class II election and until his successor is elected and qualified.
Investors also approved the First Amendment to the 2020 Omnibus Equity Incentive Plan, allowing the company to continue using equity-based awards as part of its compensation programs. Stockholders ratified the selection of Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026.
On executive pay matters, stockholders approved, on an advisory and non-binding basis, the compensation of the company’s named executive officers. In a separate advisory vote on the frequency of future say-on-pay votes, stockholders supported holding the vote every three years.
Natural Alternatives International, Inc. (NAII) filed its definitive proxy for the virtual Annual Meeting on December 5, 2025, at 11:00 a.m. PT. Stockholders will vote on six items, highlighted by an amendment to the 2020 Equity Incentive Plan to extend the term five years and increase shares authorized by 550,000 to 1,250,000.
The ballot includes: electing one Class II director (Alan G. Dunn); approving the equity plan amendment; ratifying Haskell & White LLP as auditor for fiscal year ending June 30, 2026; an advisory say‑on‑pay vote; and a say‑on‑frequency vote, with the Board recommending every three years. As of the October 13, 2025 record date, 6,176,778 shares of common stock were issued and outstanding. Directors and executive officers beneficially owned 1,282,782 shares (20.8%).
The company reports 158,877 shares remaining available under the current 2020 Plan and 541,123 shares granted and outstanding. Auditor fees were $249,000 in fiscal 2025. The meeting will be held exclusively online at https://meetnow.global/M25L7YJ, with electronic voting and Q&A available.
Natural Alternatives International, Inc. (NAII) reports key balance sheet and risk disclosures for fiscal 2025. The company had 6,178,213 shares issued and outstanding and a market capitalization of $26,717,000 based on a $4.31 close on December 31, 2024. As of June 30, 2025 the company had $1.9 million outstanding on its line of credit and $8.9 million outstanding on its term loan. On June 20, 2025 NAII entered a Sixth Amendment to its Credit Agreement extending the credit line to December 31, 2026, reducing the maximum borrowing from $12.5 million to $10.0 million and increasing borrowing costs and fees. Management disclosed a potential inability to comply with covenant requirements in early fiscal 2026 and is negotiating with the lender. The company accrued a $1.25 million maximum settlement related to employee litigation and recorded a net $1.6 million loss in OCI related to cash flow hedges. NAII states it is not aware of any material cybersecurity breaches and describes governance and IT controls.
Natural Alternatives International, Inc. (NASDAQ: NAII) filed an 8-K announcing the execution of a Sixth Amendment to its credit agreement with Wells Fargo, effective June 20, 2025.
Key terms
- Maturity extended from the current expiry to December 31, 2026, giving NAII an additional 18 months of committed bank financing.
- Revolving credit limit reduced from $12.5 million to $10 million, lowering undrawn liquidity head-room by $2.5 million.
- Collateral expanded: the company’s Carlsbad, CA powder-processing facility is now pledged, and the existing Deed of Trust is modified to secure both the term loan and the amended revolver.
- All other security agreements, including the July 1, 2019 Security Agreement, remain in force.
The amendment package consists of three executed documents (Exhibits 10.40-10.42) and is accompanied by a press release dated June 23, 2025 (Exhibit 99.9). No financial statements were included.
Management characterizes the change as a material definitive agreement (Item 1.01) and a direct financial obligation (Item 2.03). The filing provides no update on current borrowings, covenant levels or interest pricing.
FAQ
What is the current stock price of Naturl Alt Intl (NAII)?
What is the market cap of Naturl Alt Intl (NAII)?
